ScripSolutions PBM Is “Sleeper” In Chronimed/MIM Merger
The ScripSolutions PBM business may be poised for growth following the merger of MIM and Chronimed
You may also be interested in...
The HHS Inspector General will monitor prices for drugs covered under Medicare Part B to determine whether the "average sales price" accurately reflects market prices once payment rates for 2005 are finalized this fall
DPS CONTRACTING SHIFT HELPS SB INCREASE PROFIT MARGINS BY 3.7 POINTS IN FIRST QUARTER; BLISSENBACH JOINS CHRONIMED AS PRESIDENT AND CHIEF OPERATING OFFICER
A change in contracting practices by SmithKline Beecham's DPS pharmacy benefit management business contributed 2.7 percentage points to the company's pharmaceutical business operating margins during the first quarter.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011